• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用集成柠檬酸盐软件和生理钠浓度溶液进行小儿连续性肾脏替代治疗的局部柠檬酸盐抗凝。

Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions.

作者信息

Liet Jean-Michel, Allain-Launay Emma, Gaillard-LeRoux Bénédicte, Barrière François, Chenouard Alexis, Dejode Jean-Marc, Joram Nicolas

机构信息

Unité de Réanimation Pédiatrique, Pôle Femme-Enfant-Adolescent, Centre hospitalier universitaire (CHU) de Nantes, 38 Boulevard Jean-Monnet, 44093, Nantes, France,

出版信息

Pediatr Nephrol. 2014 Sep;29(9):1625-31. doi: 10.1007/s00467-014-2770-2. Epub 2014 Feb 15.

DOI:10.1007/s00467-014-2770-2
PMID:24526097
Abstract

BACKGROUND

In continuous renal replacement therapy (CRRT), regional citrate anticoagulation offers an attractive alternative to heparinization, especially for children with a high bleeding risk.

METHODS

We report on a new management approach to CRRT using integrated citrate software and physiological sodium concentration solutions. Convective filtration was performed with pre-filter citrate anticoagulation using an 18 mmol/L citrate solution and a post-filter replacement fluid. The citrate flow rate was automatically adjusted to the blood flow rate by means of integrated citrate software. Similarly, calcium was automatically infused into children to maintain their blood calcium levels within normal range.

RESULTS

Eleven CRRT sessions were performed (330 h) in seven critically ill children aged 3-15 years (extreme values 15-66 kg). Disease categories included sepsis with multiorgan dysfunction (n = 2) and hemolytic uremic syndrome (n = 5). Median effluent dose was 2.1 (extreme values 1.7-3.3) L/h/1.73 m2. No session had to be stopped because of metabolic complications. Calcium levels, both in the circuits and in the circulating blood of the children, remained stable and secure.

CONCLUSIONS

Regional citrate anticoagulation can be used in children with a body weight of >15 kg using integrated citrate software and commercially available solutions with physiological sodium concentrations in a safe, effective and convenient procedure.

摘要

背景

在连续性肾脏替代治疗(CRRT)中,局部枸橼酸盐抗凝是肝素抗凝的一种有吸引力的替代方法,尤其适用于出血风险高的儿童。

方法

我们报告一种使用集成枸橼酸盐软件和生理钠浓度溶液的CRRT新管理方法。采用18 mmol/L枸橼酸盐溶液进行滤器前枸橼酸盐抗凝及滤器后置换液进行对流过滤。通过集成枸橼酸盐软件将枸橼酸盐流速自动调整至血流速度。同样,自动给儿童输注钙剂以维持其血钙水平在正常范围内。

结果

对7例3 - 15岁危重症儿童进行了11次CRRT治疗(共330小时)(体重极值为15 - 66 kg)。疾病类型包括伴有多器官功能障碍的脓毒症(n = 2)和溶血尿毒综合征(n = 5)。中位超滤剂量为2.1(极值为1.7 - 3.3)L/h/1.73 m²。没有因代谢并发症而停止治疗的情况。回路及儿童循环血液中的钙水平均保持稳定和安全。

结论

使用集成枸橼酸盐软件和具有生理钠浓度的市售溶液,局部枸橼酸盐抗凝可安全、有效且方便地用于体重>15 kg的儿童。

相似文献

1
Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions.使用集成柠檬酸盐软件和生理钠浓度溶液进行小儿连续性肾脏替代治疗的局部柠檬酸盐抗凝。
Pediatr Nephrol. 2014 Sep;29(9):1625-31. doi: 10.1007/s00467-014-2770-2. Epub 2014 Feb 15.
2
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.柠檬酸盐与肝素抗凝在小儿连续性肾脏替代治疗中的比较。
Pediatr Nephrol. 2017 Oct;32(10):1971-1978. doi: 10.1007/s00467-017-3694-4. Epub 2017 Jun 4.
3
Citrate clearance in children receiving continuous venovenous renal replacement therapy.接受持续静静脉肾脏替代治疗的儿童的枸橼酸盐清除率
Pediatr Nephrol. 2002 Oct;17(10):819-24. doi: 10.1007/s00467-002-0963-6. Epub 2002 Sep 7.
4
Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.局部枸橼酸抗凝在肝衰竭患者连续性肾脏替代治疗中的安全性和有效性:系统评价和荟萃分析。
Crit Care. 2019 Jan 24;23(1):22. doi: 10.1186/s13054-019-2317-9.
5
Regional citrate anticoagulation for pediatric CRRT using integrated citrate software.使用集成柠檬酸盐软件的小儿连续性肾脏替代治疗的局部柠檬酸盐抗凝法
Pediatr Nephrol. 2014 Sep;29(9):1647. doi: 10.1007/s00467-014-2881-9. Epub 2014 Aug 7.
6
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.出血高危心脏手术患者的局部枸橼酸盐抗凝:采用低浓度枸橼酸盐溶液的持续静脉-静脉血液滤过方案
Crit Care. 2012 Jun 27;16(3):R111. doi: 10.1186/cc11403.
7
Regional citrate anticoagulation for continuous renal replacement therapy in children.儿童连续性肾脏替代治疗中的局部枸橼酸盐抗凝
Pediatr Nephrol. 2017 Apr;32(4):703-711. doi: 10.1007/s00467-016-3544-9. Epub 2016 Nov 28.
8
Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.区域枸橼酸盐抗凝在小儿肝衰竭患者连续性肾脏替代治疗中的应用
PLoS One. 2017 Aug 8;12(8):e0182134. doi: 10.1371/journal.pone.0182134. eCollection 2017.
9
Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.在连续性肾脏替代治疗中,局部枸橼酸盐抗凝是否优于全身肝素抗凝?一项在成人区域重症监护系统中的前瞻性观察研究。
J Crit Care. 2005 Jun;20(2):155-61. doi: 10.1016/j.jcrc.2005.01.001.
10
Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement.用于连续性肾脏替代治疗(CRRT)且无需补充钙剂的简化枸橼酸盐抗凝法
ASAIO J. 2015 Jul-Aug;61(4):437-42. doi: 10.1097/MAT.0000000000000226.

引用本文的文献

1
Regional citrate anticoagulation algorithm and management protocol aimed at ensuring blood calcium stability: a prospective single-arm study.旨在确保血钙稳定性的局部枸橼酸盐抗凝算法及管理方案:一项前瞻性单臂研究。
Clin Kidney J. 2025 Jul 12;18(8):sfaf230. doi: 10.1093/ckj/sfaf230. eCollection 2025 Aug.
2
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children.危重症儿童连续性肾脏替代治疗中柠檬酸盐抗凝与全身肝素抗凝。
Pediatr Res. 2024 Aug;96(3):702-712. doi: 10.1038/s41390-024-03163-x. Epub 2024 Mar 30.
3
Evaluation of the efficacy and associated complications of regional citrate anticoagulation in neonates: experience from a fourth level neonatal intensive care unit.

本文引用的文献

1
Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry.10 公斤以下儿童连续性肾脏替代治疗:前瞻性儿科连续性肾脏替代治疗登记研究报告。
J Pediatr. 2013 Mar;162(3):587-592.e3. doi: 10.1016/j.jpeds.2012.08.044. Epub 2012 Oct 24.
2
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.肝功能衰竭患者采用局部枸橼酸抗凝的持续静脉-静脉血液透析:一项前瞻性观察研究。
Crit Care. 2012 Aug 22;16(4):R162. doi: 10.1186/cc11485.
3
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
评价局部枸橼酸抗凝在新生儿中的疗效及相关并发症:来自四级新生儿重症监护病房的经验。
Eur J Pediatr. 2023 Nov;182(11):4897-4908. doi: 10.1007/s00431-023-05162-2. Epub 2023 Aug 19.
4
A simplified protocol of regional citrate anticoagulation with phosphate-containing solutions in infants and children treated with continuous kidney replacement therapy.连续肾脏替代治疗中婴幼儿应用含磷酸盐溶液的局部枸橼酸抗凝简化方案。
Pediatr Nephrol. 2023 Nov;38(11):3835-3844. doi: 10.1007/s00467-023-05994-y. Epub 2023 May 24.
5
Regional citrate anticoagulation for continuous renal replacement therapy in newborns.新生儿连续性肾脏替代治疗中的局部枸橼酸盐抗凝
Front Pediatr. 2023 Mar 8;11:1089849. doi: 10.3389/fped.2023.1089849. eCollection 2023.
6
Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.急性肾损伤行肾脏替代治疗患者的抗凝治疗。
Pediatr Nephrol. 2022 Oct;37(10):2303-2330. doi: 10.1007/s00467-021-05020-z. Epub 2021 Oct 19.
7
Effect of adult COVID-19 surge on the provision of kidney replacement therapy in children.成人新冠疫情激增对儿童肾脏替代治疗供应的影响。
Pediatr Nephrol. 2020 Nov;35(11):2023-2030. doi: 10.1007/s00467-020-04723-z. Epub 2020 Aug 5.
8
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.儿童 2019 冠状病毒病急性肾损伤及肾脏替代治疗的特殊考虑:来自欧洲儿童和新生儿重症监护学会重症肾脏病学组的观点。
Blood Purif. 2021;50(2):150-160. doi: 10.1159/000509677. Epub 2020 Jul 14.
9
Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children.含钙剂替代物用于儿童连续性血液滤过的局部枸橼酸盐抗凝法。
Medicine (Baltimore). 2019 Oct;98(40):e17421. doi: 10.1097/MD.0000000000017421.
10
Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.区域枸橼酸盐抗凝在小儿肝衰竭患者连续性肾脏替代治疗中的应用
PLoS One. 2017 Aug 8;12(8):e0182134. doi: 10.1371/journal.pone.0182134. eCollection 2017.
出血高危心脏手术患者的局部枸橼酸盐抗凝:采用低浓度枸橼酸盐溶液的持续静脉-静脉血液滤过方案
Crit Care. 2012 Jun 27;16(3):R111. doi: 10.1186/cc11403.
4
Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.儿科血液透析治疗中标准未分级肝素的替代选择。
Pediatr Nephrol. 2012 Oct;27(10):1869-79. doi: 10.1007/s00467-012-2129-5. Epub 2012 Feb 29.
5
Continuous renal replacement therapy in children.儿童连续性肾脏替代治疗。
Pediatr Nephrol. 2012 Nov;27(11):2007-2016. doi: 10.1007/s00467-011-2080-x. Epub 2012 Feb 28.
6
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.区域枸橼酸抗凝与肝素抗凝用于连续性肾脏替代治疗的荟萃分析:随机对照试验的荟萃分析。
Am J Kidney Dis. 2012 Jun;59(6):810-8. doi: 10.1053/j.ajkd.2011.11.030. Epub 2012 Jan 5.
7
Regional citrate anticoagulation in critically ill patients with liver and kidney failure.危重症肝肾衰竭患者的局部枸橼酸抗凝。
J Nephrol. 2012 Jan-Feb;25(1):113-9. doi: 10.5301/JN.2011.8363.
8
Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy.危重症儿童持续肾脏替代治疗的临床病程和死亡风险因素。
Intensive Care Med. 2010 May;36(5):843-9. doi: 10.1007/s00134-010-1858-9. Epub 2010 Mar 18.
9
Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children.危重症儿童连续肾脏替代治疗中氨基酸、微量元素和叶酸的清除率
Intensive Care Med. 2009 Apr;35(4):698-706. doi: 10.1007/s00134-009-1420-9. Epub 2009 Jan 29.
10
Controversies in paediatric continuous renal replacement therapy.儿科连续性肾脏替代治疗中的争议
Intensive Care Med. 2009 Apr;35(4):596-602. doi: 10.1007/s00134-009-1425-4. Epub 2009 Jan 31.